Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Cantel Medical said it agreed to put up $26.9 million in cash to acquire PuriCore International, a British endoscope reprocessing company.
The move is a bid to expand Cantel’s footprint in international markets, according to a press release. PuriCore International put up revenues of roughly $25 million last year, according to the release. Read more
Senator Angus King (I-Maine) has a new bill on the floor that he says will correct a fundamental imbalance in the medtech market, namely by imposing more pricing transparency on medical device makers.
He started out researching the controversial medical device tax, he said on the Senate floor this week, but his research into medtech’s share of the cost of U.S. healthcare hit a wall when he couldn’t turn up information on how much hospitals are paying for various implantable devices. Given the growing emphasis on reigning in healthcare costs, the lack of transparency in medical devices may be hindering market forces that may otherwise help lower prices, King said. Read more
A federal judge yesterday granted a bid by the family of the late physician who helped invent the implantable cardioverter defibrillator, Dr. Michel Mirowski, to send a $570 million lawsuit against Boston Scientific back to a Maryland state court.
Judge William Quarles Jr. of the U.S. District Court for Maryland found that Boston Scientific’s removal of the case to the federal court was untimely, according to court documents. Read more